Generate a tailored SOP for Dr. Alanna Schepartz. Improve your application with a focused, well-structured draft.
Alanna Schepartz is the CZ Irmgard Distinguished Chair in Chemistry at the University of California, Berkeley. She conducts research in the field of Molecular Therapeutics, contributing to the understanding of molecular interactions and drug design. Her laboratory focuses on the development of novel therapeutic strategies using an interdisciplinary approach that combines chemistry, biology, and materials science. Schepartz has published extensively in forensic research and therapeutics, aiming to bridge the gap between scientific innovation and practical applications in medicine.
The Mathematics Subject GRE is required for the Fall 2026 admissions cycle. General GRE is optional.